XML 20 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents ($462 and $491 related to VIEs) $ 2,335 $ 2,519
Marketable securities 74 69
Accounts receivable, net ($212 and $135 related to VIEs) 1,099 1,137
Contract assets ($167 and $171 related to VIEs) 1,002 991
Other current assets ($55 and $50 related to VIEs) 401 347
Total current assets 4,911 5,063
Noncurrent assets    
Property, plant and equipment, net ($46 and $41 related to VIEs) 438 458
Investments 632 614
Deferred taxes 34 51
Deferred compensation trusts 210 241
Goodwill 206 206
Other assets ($77 and $127 related to VIEs) 269 340
Total noncurrent assets 1,789 1,910
Total assets 6,700 6,973
Current liabilities    
Accounts payable ($290 and $285 related to VIEs) 1,248 1,214
Contract liabilities ($317 and $276 related to VIEs) 652 639
Accrued salaries, wages and benefits ($26 and $25 related to VIEs) 529 653
Other accrued liabilities ($77 and $73 related to VIEs) 518 657
Total current liabilities 2,947 3,163
Long-term debt 1,149 1,158
Deferred taxes 72 70
Other noncurrent liabilities ($12 and $20 related to VIEs) 488 530
Commitments and contingencies
Shareholders’ equity    
Common stock — authorized 375,000,000 shares ($0.01 par value); issued and outstanding — 171,209,311 and 170,405,512 shares in 2024 and 2023, respectively 2 2
APIC 1,230 1,228
AOCI (319) (269)
Retained earnings 1,038 979
Total shareholders’ equity 1,951 1,940
NCI 93 112
Total equity 2,044 2,052
Total liabilities and equity $ 6,700 $ 6,973